Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News CTI BioPharma Corp. CTIC

Healthcare Biotechnology
CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under pipeline include PIXUVRI, and Pacritinib. PIXUVRI is a novel aza-anthracenedione with unique structural and physiochemical properties. Pacritinib is an investigational... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CTIC)

No current news is available.
View More News ››

Opinion & Analysis (NDAQ:CTIC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CTIC)

Real Time 4 $$

CTICCTI BIOPHARMA COUS $ 4.00 0.05 ...
Goldy63 - March 4, 2022

OPPS . Monday March 7th .

Thats what you get when your eating and typng at the same time lol. TGIF.  CTI BioPharma to Present at the Cowen 42nd Annual...
Goldy63 - March 4, 2022

Monday Feb 7th . Numbers= $$$ = BOOM .

CTI BioPharma to Present at the Cowen 42nd Annual Healthcare Conference     CTIC ...
Goldy63 - March 4, 2022

And From What I Heard

There ready to start producing and selling to the conservative tune of get this . 750 Million $ to start . Huh !!!!! . Dam thats not...
Goldy63 - March 3, 2022

And This Yesterday . Huge Eyes Coming.

CTI BioPharma to Present at the Cowen 42nd Annual Healthcare Conference CTIC | 23 hours ago ...
Goldy63 - March 3, 2022

Hey Tango . Huge News , Dead Board So Yup 2 Days Ago .

CTI BioPharma Announces FDA Accelerated Approval of VONJO(TM) (pacritinib) for the Treatment of Adult Patients with Myelofibrosis...
Goldy63 - March 3, 2022
View more Bullboard ››

K9 Gold Corp

K9 Gold Corp

K9 Gold Corp. is engaged in the business of identification, acquisition and exploration of mineral interests. The Company’s ...
View More »